About: Results of the CONFIRM phase IIItrial comparing fulvestrant 250 mg with fulvestrant 500 mg in postmenopausal women with estrogen receptor

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Results of the CONFIRM phase IIItrial comparing fulvestrant 250 mg with fulvestrant 500 mg in postmenopausal women with estrogen receptor–positive advanced breast cancer Goto Sponge NotDistinct Permalink

An Entity of Type : http://linked.opendata.cz/ontology/domain/vavai/Vysledek, within Data Space : linked.opendata.cz associated with source document(s)

Attributes	Values
rdf:type	skos:Concept http://linked.opendata.cz/ontology/domain/vavai/Vysledek
Description	Annotation: Summary - The CONFIRM trial has shown a statistically significant increase in TTP for F500 compared with F250 in postemenopausal women, without increase in toxicity. Annotation: Summary - The CONFIRM trial has shown a statistically significant increase in TTP for F500 compared with F250 in postemenopausal women, without increase in toxicity. (en)
Title	Results of the CONFIRM phase IIItrial comparing fulvestrant 250 mg with fulvestrant 500 mg in postmenopausal women with estrogen receptor–positive advanced breast cancer Results of the CONFIRM phase IIItrial comparing fulvestrant 250 mg with fulvestrant 500 mg in postmenopausal women with estrogen receptor–positive advanced breast cancer (en)
skos:prefLabel	Results of the CONFIRM phase IIItrial comparing fulvestrant 250 mg with fulvestrant 500 mg in postmenopausal women with estrogen receptor–positive advanced breast cancer Results of the CONFIRM phase IIItrial comparing fulvestrant 250 mg with fulvestrant 500 mg in postmenopausal women with estrogen receptor–positive advanced breast cancer (en)
skos:notation	RIV/00064165:_____/10:8258!RIV11-MZ0-00064165
http://linked.open...avai/riv/aktivita	V
http://linked.open...avai/riv/aktivity	V
http://linked.open...iv/cisloPeriodika	30
http://linked.open...vai/riv/dodaniDat	2011
http://linked.open...aciTvurceVysledku	Petruželka, Luboš
http://linked.open.../riv/druhVysledku	J - Článek v odborném periodiku
http://linked.open...iv/duvernostUdaju	S - Úplné a pravdivé údaje nepodléhající ochraně podle zvláštních právních předpisů
http://linked.open...titaPredkladatele	Všeobecná fakultní nemocnice v Praze / (nerozlišená součást)
http://linked.open...dnocenehoVysledku	285079
http://linked.open...ai/riv/idVysledku	RIV/00064165:_____/10:8258
http://linked.open...riv/jazykVysledku	eng - angličtina
http://linked.open.../riv/klicovaSlova	Breast cancer; postmenopausal women; fulvestrant; estrogen; CONFIRM trial (en)
http://linked.open.../riv/klicoveSlovo	Breast cancer estrogen CONFIRM trial postmenopausal women fulvestrant
http://linked.open...odStatuVydavatele	US - Spojené státy americké
http://linked.open...ontrolniKodProRIV	[B698155702A6]
http://linked.open...i/riv/nazevZdroje	Journal of Clinical Oncology
http://linked.open...in/vavai/riv/obor	FD
http://linked.open...ichTvurcuVysledku	1 (xsd:int)
http://linked.open...cetTvurcuVysledku	15 (xsd:int)
http://linked.open...UplatneniVysledku	2010
http://linked.open...v/svazekPeriodika	28
http://linked.open...iv/tvurceVysledku	Petruželka, Luboš Di Leo, Angelo Jerusalem, Guy Khasanov, Rustem Martin, Miguel Pendergrass, Kelly Torres, Roberto Verhoeven, Didier Bondarenko, Igor, N. Garnett, Sally Lichinitser, Mikhail, R. Lindemann, Justin, P. O. Pedrini, Jose, L. Sapunar, Francisco Smirnova, Iya
http://linked.open...ain/vavai/riv/wos	000283056400027
issn	0732-183X
number of pages	7 (xsd:int)

Faceted Search & Find service v1.16.118 as of Jun 21 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3240 as of Jun 21 2024, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (126 GB total memory, 58 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software